A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Clinical trial NCT05941507 · RECRUITING
Trial details
- NCT number
- NCT05941507
- Sponsor
- LigaChem Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2027-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.